Previous 10 |
home / stock / tbpmf / tbpmf news
ORLEANS, Ontario, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP) (OTCQB: TBPMF), today announced that it has temporarily suspended its phase 3 clinical program due to impurities found in its PPP001 investigational drug being administ...
Crescita Therapeutics ( OTC:CRRTF ) and Tetra Natural Health, a subsidiary of Tetra Bio-Pharma ( OTCQB:TBPMF ) collaborates to develop an enhanced version of Tetra's dermatology portfolio using Crescita's patented transdermal delivery technologies: Multiplexed Molecular Penetration Enhancer ...
LAVAL, Quebec, and ORLEANS, Ontario, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Crescita Therapeutics Inc. ("Crescita") (TSX: CTX), a Canadian commercial dermatology company and Tetra Natural Health (NHP), a subsidiary of Tetra Bio-Pharma, a leader in cannabinoid-derived drug discovery and developme...
Tetra Bio-Pharma ( OTCQB:TBPMF ) has agreed to acquire cannabinoid-based drug developer Panag Pharma for $12M in cash and stock. More news on: Tetra Bio-Pharma Inc., Healthcare stocks news, Merger & acquisition news, Read more ...
Tetra Bio-Pharma Enters into Definitive Agreement to Acquire Panag Pharma Inc. Canada NewsWire ORLEANS, ON, Jan. 30, 2019 The Proposed Transaction is expected to: provide Tetra with the most robust Pharmaceutical and Natural Health Products pipeline of any Cannabino...
ORLEANS, Ontario, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc (“ Tetra ” or the “ Company ”) (TSX VENTURE: TBP) (OTCQB: TBPMF), a leader in cannabinoid-based drug discovery and development has announced that it filed a patent applicati...
News, Short Squeeze, Breakout and More Instantly...
Tetra Bio-Pharma Inc Company Name:
TBPMF Stock Symbol:
OTCMKTS Market:
Tetra Bio-Pharma Inc Website:
(TheNewswire) Montreal – TheNewswire - August 1, 2023 – Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Company ”) ( TSX:TBP ) ( OTC:TBPMF ) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development announced that...
(TheNewswire) MONTREAL, QUEBEC – TheNewswire – May 11, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development, today announced it has cancelled its New Drug Subm...
(TheNewswire) Montreal, QC - TheNewswire - March 10, 2023 - Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1) , a leader in cannabinoid-derived drug discovery and development is pleased to announce Health Canada h...